In this study, the ANN approach was applied to
analyze COVID-19 deaths in Ecuador. The employed data covers the period 1
January 2020 to 20 April 2021 and the out-of-sample period ranges over the
period21 April to 31 August 2021. The residuals and forecast evaluation
criteria (Error, MSE and MAE) of the applied model indicate that the model is
quite stable. The results of the study indicate that
daily COVID-19 deaths in Ecuador are likely to be close to 40 deaths per day
over the out-of-sample period. Therefore there is need for the government of
Ecuador to ensure adherence to safety guidelines while continuing to create
awareness about the COVID-19 pandemic and scale up COVID-19 vaccination.
Country : Zimbabwe
1 Dr. Smartson. P. NYONI2 Mr. Thabani NYONI3 Mr. Tatenda. A. CHIHOHO
ZICHIRe Project, University of Zimbabwe, Harare, Zimbabwe
K. Karunathilake
(2020). Positive and negative impacts of COVID‑19, an analysis
with special reference to challenges on the supply chain
in South Asian countries, Journal of Social and Economic Development https://doi.org/10.1007/s40847-020-00107-z,
pp 1-14.
Eric Toner (2021).
Potential Solutions to the COVID-19 Oxygen Crisis in the United States , Johns
Hopkins Center for Health Security, centerforhealthsecurity.org, pp 1-3.
CDC (2020). The Novel
Coronavirus Pneumonia Emergency Response Epidemiology Team, The epidemiological
characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in
China. China CDC Weekly 2, 113–122
Read et al (2020).
Novel coronavirus 2019-nCoV: Earlyestimationofepidemiologicalparametersandepidemicpredictions.
medRxiv:10.1101/2020.01.23.20018549
Tang. B et al
(2020). An updated estimation of the
risk of transmission of the novel coronavirus (2019-nCoV). Infectious Disease
Modelling 5, 248–255.
Tang. B et al (2020).
Estimation of the transmission risk of the 2019-nCoV and its implication for
public health interventions. J. Clinical Med. 9, 462.
Wang D et al
(2020). Clinical characteristics of 138
hospitalized patients with 2019 novel coronavirus–infected pneumonia in Wuhan, China.
JAMA 323, 1061–1069.
Wang H et al (2020).
Phase-adjusted estimation of the number of coronavirus disease 2019 cases in
Wuhan, China. Cell Discovery 6, 76.
Wang. W et al (2020).
Updated understanding of the outbreak of 2019 novel coronavirus (2019-nCoV) in
Wuhan, China. J. Med. Virology 92, 441–447.
ILO (2020). ILO
Monitor: COVID-19 and the world of work. Second edition, pp 1-11.